← All organizations
Highest phase reached
Phase 3
Timeline
2010s
- Jun 1, 2018
Nuvation Bio Inc.— Founded
2020s
- Jun 11, 2025
taletrectinib— Marketing Organization
Drugs by trial phase (7 distinct, 7 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (6 own, 0 via acquisition)
Indications
Studied for
Marketed drugs (1)
Recent trials (7)
- NCT06841874Lead sponsorN/A—
- NCT07154706Lead sponsorPhase 3Aug 21, 2025
- NCT06334432Lead sponsorPhase 1/Phase 2Mar 14, 2024
- NCT05191017Lead sponsorPhase 1/Phase 2Sep 30, 2022
- NCT05191004Lead sponsorPhase 1/Phase 2Sep 30, 2022
- NCT05252390Lead sponsorPhase 1/Phase 2Mar 29, 2022
- NCT04541225Lead sponsorPhase 1/Phase 2Nov 4, 2020
Details
- Founded
- New York, NY, US Jun 1, 2018
- Last known activity
- Aug 21, 2025